MedPointe Healthcare Inc. v. Apotex Inc.
1:06-cv-00164
Overview
Parties
Defendant
Apotex Corp. Operating Company
Represented By
11 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Morris James LLP
500 Delaware Avenue, Suite 1500
Delaware Department of Justice
Delaware Department of Justice, 391 Lukens Drive
Apotex Inc. Operating Company
Represented By
6 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Morris James LLP
500 Delaware Avenue, Suite 1500
Delaware Department of Justice
Delaware Department of Justice, 391 Lukens Drive
Plaintiff
Meda Pharmaceuticals Inc. Operating Company
Represented By
7 Attorneys ListedRichards, Layton & Finger
Richards, Layton & Finger, One Rodney Square
Delaware Department of Justice
Delaware Department of Justice, 391 Lukens Drive
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → |
Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
MedPointe Healthcare Inc. v. Sun Pharmaceutical Industries Ltd.
MedPointe Healthcare Inc. v. Apotex Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5164194
Azelastine containing medicaments
|
Filed: 1990-07-12
Issued: 1992-11-17
|
Expired (Term Ended)
+112d PTA
Expires: 2010-11-01
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
0
Granted
0
Denied
0
Pending / Review
4
Motions by Category
Key Dispositive Motions & Rulings